Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11955)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abd El-Haleim EA, Bahgat AK, Saleh S. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. World J Gastroenterol 2016; 22(10): 2931-2948 [PMID: 26973390 DOI: 10.3748/wjg.v22.i10.2931] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i10/2931.htm |
| Number | Citing Articles |
| 1 |
Milad Ashrafizadeh, Masoud Najafi, Sima Orouei, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Negin Sharifi, Kiavash Hushmandi, Ali Zarrabi, Kwang Seok Ahn. Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities. Biomedicines 2020; 8(8): 261 doi: 10.3390/biomedicines8080261
|
| 2 |
Tian Kang, Wei-Li Sun, Xiao-Fei Lu, Xin-Liang Wang, Lian Jiang. MiR-28-5p mediates the anti-proliferative and pro-apoptotic effects of curcumin on human diffuse large B-cell lymphoma cells. Journal of International Medical Research 2020; 48(7): 030006052094379 doi: 10.1177/0300060520943792
|
| 3 |
Putri Anggreini, Hadi Kuncoro, Sri Sumiwi, Jutti Levita. Role of the AMPK/SIRT1 pathway in non‑alcoholic fatty liver disease (Review). Molecular Medicine Reports 2022; 27(2) doi: 10.3892/mmr.2022.12922
|
| 4 |
Zhenhua Ma, Yangmin Zhang, Qingchun Li, Meng Xu, Jigang Bai, Shengli Wu, Wenke Feng. Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production. PLOS ONE 2017; 12(8): e0183426 doi: 10.1371/journal.pone.0183426
|
| 5 |
Hala Attia, Norah Albekairi, Layal Albdeirat, Arwa Soliman, Reem Rajab, Hend Alotaibi, Rehab Ali, Amira Badr, Jolanta Czuczejko. Chrysin Attenuates Fructose-Induced Nonalcoholic Fatty Liver in Rats via Antioxidant and Anti-Inflammatory Effects: The Role of Angiotensin-Converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/9479456
|
| 6 |
Ali Mahmoudi, Seyed Adel Moallem, Thomas P. Johnston, Amirhossein Sahebkar, Stéphane Mandard. Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models. PPAR Research 2022; 2022: 1 doi: 10.1155/2022/5805398
|
| 7 |
Rasha R. Radwan, Hesham F. Hasan. Pioglitazone ameliorates hepatic damage in irradiated ratsviaregulating anti-inflammatory and antifibrogenic signalling pathways. Free Radical Research 2019; 53(7): 748 doi: 10.1080/10715762.2019.1624742
|
| 8 |
Sabine Weiskirchen, Ralf Weiskirchen. Resveratrol: Is It Really Good for Liver Health?. Hepatitis Monthly 2017; 17(8) doi: 10.5812/hepatmon.12074
|
| 9 |
Yen-Wei Chen, Graciel Diamante, Jessica Ding, Thien Xuan Nghiem, Jessica Yang, Sung-Min Ha, Peter Cohn, Douglas Arneson, Montgomery Blencowe, Jennifer Garcia, Nima Zaghari, Paul Patel, Xia Yang. PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool. iScience 2022; 25(4): 104052 doi: 10.1016/j.isci.2022.104052
|
| 10 |
Zongying Li, Shuyi Cao. Pre-incubation with human umbilical cord derived mesenchymal stem cells-exosomes prevents cisplatin-induced renal tubular epithelial cell injury. Aging 2020; 12(18): 18008 doi: 10.18632/aging.103545
|
| 11 |
Yasmine A Abdelhamid, Mohammed F Elyamany, Muhammad Y Al-Shorbagy, Osama A Badary. Effects of TNF-α antagonist infliximab on fructose-induced metabolic syndrome in rats. Human & Experimental Toxicology 2021; 40(5): 801 doi: 10.1177/0960327120969960
|
| 12 |
Zhao Yang, Katherine Roth, Manisha Agarwal, Wanqing Liu, Michael C. Petriello. The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. The Journal of Nutritional Biochemistry 2021; 95: 108633 doi: 10.1016/j.jnutbio.2021.108633
|
| 13 |
Alfredo Fernández-Quintela, Marcela González, Leixuri Aguirre, Iñaki Milton-Laskibar, Asier Léniz, Maria P. Portillo. The Liver. 2018; : 199 doi: 10.1016/B978-0-12-803951-9.00017-3
|
| 14 |
Asmaa M. Hamed, Omnyah A. El-Kharashi, Suzi S.A. Boctor, Lobna F. Abd-Elaziz. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD. Biomedicine & Pharmacotherapy 2017; 85: 68 doi: 10.1016/j.biopha.2016.11.114
|
| 15 |
Yu-Cheng Li, Jing-Yi Qiao, Bao-Ying Wang, Ming Bai, Ji-Duo Shen, Yong-Xian Cheng. Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways. Nutrients 2018; 10(8): 1024 doi: 10.3390/nu10081024
|
| 16 |
Pengyuan Zhang, Lijuan Xu, Hongyu Guan, Liehua Liu, Juan Liu, Zhimin Huang, Xiaopei Cao, Zhihong Liao, Haipeng Xiao, Yanbing Li. Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway. Metabolism 2017; 73: 9 doi: 10.1016/j.metabol.2017.05.003
|
| 17 |
Nikolaos Perakakis, Wael Ghaly, Natia Peradze, Chrysoula Boutari, Saime Batirel, Vivian Paraskevi Douglas, Christos S. Mantzoros. Research advances in metabolism 2017. Metabolism 2018; 83: 280 doi: 10.1016/j.metabol.2018.01.018
|
| 18 |
Yu Yang, Yu Zhao, Wenzhen Li, Yuyao Wu, Xin Wang, Yijie Wang, Tingmei Liu, Tinghong Ye, Yongmei Xie, Zhiqiang Cheng, Jun He, Peng Bai, Yiwen Zhang, Liang Ouyang. Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. European Journal of Medicinal Chemistry 2020; 197: 112311 doi: 10.1016/j.ejmech.2020.112311
|
| 19 |
Tanja Eberhart, Miriam J. Schönenberger, Katharina M. Walter, Khanichi N. Charles, Phyllis L. Faust, Werner J. Kovacs. Peroxisome-Deficiency and HIF-2α Signaling Are Negative Regulators of Ketohexokinase Expression. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00566
|
| 20 |
Reza Afarin, Fereshteh Aslani, Shahla Asadizade, Bahar Jaberian Asl, Mehrnoosh Mohammadi Gahrooie, Elham Shakerian, Akram Ahangarpour. The Effect of Lipopolysaccharide-Stimulated Adipose-Derived Mesenchymal Stem Cells on NAFLD Treatment in High-Fat Diet-Fed Rats. Iranian Journal of Pharmaceutical Research 2023; 22(1) doi: 10.5812/ijpr-134807
|
| 21 |
Alba Serrano, Joan Ribot, Andreu Palou, M. Luisa Bonet. Long-term programming of skeletal muscle and liver lipid and energy metabolism by resveratrol supplementation to suckling mice. The Journal of Nutritional Biochemistry 2021; 95: 108770 doi: 10.1016/j.jnutbio.2021.108770
|
| 22 |
Ali Mahmoudi, Tannaz Jamialahmadi, Thomas P. Johnston, Amirhossein Sahebkar. Impact of fenofibrate on NAFLD/NASH: A genetic perspective. Drug Discovery Today 2022; 27(8): 2363 doi: 10.1016/j.drudis.2022.05.007
|
| 23 |
Pan Li, Ruoyu Zhang, Meng Wang, Yuwei Chen, Zhiwei Chen, Xiumei Ke, Ling Zuo, Jianwei Wang. Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.917329
|
| 24 |
Babalwa Unice Jack, Pritika Ramharack, Christiaan Malherbe, Kwazi Gabuza, Elizabeth Joubert, Carmen Pheiffer. Cyclopia intermedia (Honeybush) Induces Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor Alpha Expression in Obese Diabetic Female db/db Mice. International Journal of Molecular Sciences 2023; 24(4): 3868 doi: 10.3390/ijms24043868
|
| 25 |
Asier Léniz, Daniel Martínez-Maqueda, Alfredo Fernández-Quintela, Jara Pérez-Jiménez, María P. Portillo. Potential Relationship between the Changes in Circulating microRNAs and the Improvement in Glycaemic Control Induced by Grape Pomace Supplementation. Foods 2021; 10(9): 2059 doi: 10.3390/foods10092059
|
| 26 |
Luana Cristina Faria Carvalho, Bruna Vidal Bruna, Sttefany Viana Gomes, Cláudia Martins Carneiro, Daniela Caldeira Costa. Temporal effect of fructose supplementation at different concentrations on hepatic metabolism of Wistar rats. Nutrición Hospitalaria 2021; doi: 10.20960/nh.03691
|
| 27 |
Trine V. Dam, Nicolaj I. Toft, Lars Grøntved. Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD. Cells 2022; 11(5): 870 doi: 10.3390/cells11050870
|
| 28 |
Shibin Ding, Jinjin Jiang, Guofu Zhang, Yongjun Bu, Guanghui Zhang, Xiangmei Zhao, Marcia B. Aguila. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats. PLOS ONE 2017; 12(8): e0183541 doi: 10.1371/journal.pone.0183541
|
| 29 |
Adrian Zubrzycki, Agata Wrońska, Anna Kotulak-Chrząszcz, Piotr Mieczysław Wierzbicki, Zbigniew Kmieć. Fenofibrate impairs liver function and structure more pronounced in old than young rats. Archives of Gerontology and Geriatrics 2020; 91: 104244 doi: 10.1016/j.archger.2020.104244
|
| 30 |
Mariano Nicolás Alemán, Sara Serafina Sánchez, Stella Maris Honoré. Daily Intake of Smallanthus sonchifolius (Yacon) Roots Reduces the Progression of Non-alcoholic Fatty Liver in Rats Fed a High Fructose Diet. Plant Foods for Human Nutrition 2022; 77(4): 521 doi: 10.1007/s11130-022-01009-7
|
| 31 |
Kim H.H. Liss, Brian N. Finck. PPARs and nonalcoholic fatty liver disease. Biochimie 2017; 136: 65 doi: 10.1016/j.biochi.2016.11.009
|
| 32 |
CAROLINA A. MIRANDA, TATIELE E. SCHÖNHOLZER, EDUARDO KLÖPPEL, YURI K. SINZATO, GUSTAVO T. VOLPATO, DÉBORA C. DAMASCENO, KLEBER E. CAMPOS. Repercussions of low fructose-drinking water in male rats. Anais da Academia Brasileira de Ciências 2019; 91(1) doi: 10.1590/0001-3765201920170705
|
| 33 |
Aya Galal, Wesam M. El-Bakly, Sara S. El-Kilany, Azza A. Ali, Ebtehal El-Demerdash. Fenofibrate ameliorates olanzapine’s side effects without altering its central effect: emphasis on FGF-21–adiponectin axis. Behavioural Pharmacology 2021; 32(8): 615 doi: 10.1097/FBP.0000000000000656
|
| 34 |
Amanda Karolina Soares Silva, Christina Alves Peixoto. Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation. Cellular and Molecular Life Sciences 2018; 75(16): 2951 doi: 10.1007/s00018-018-2838-4
|
| 35 |
I. Milton-Laskibar, L. Aguirre, U. Etxeberria, F. I. Milagro, J. A. Martínez, María P. Portillo. Involvement of autophagy in the beneficial effects of resveratrol in hepatic steatosis treatment. A comparison with energy restriction. Food & Function 2018; 9(8): 4207 doi: 10.1039/C8FO00930A
|
| 36 |
Enas Ahmed Abd El-Haleim. Molecular Study on the Potential Protective Effects of Bee Venom against Fructose-Induced Nonalcoholic Steatohepatitis in Rats. Pharmacology 2020; 105(11-12): 692 doi: 10.1159/000508511
|
| 37 |
Leonie Gellrich, Daniel Merk. Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Nuclear Receptor Research 2017; 4 doi: 10.11131/2017/101310
|
| 38 |
Iman Alqarni, Yieldez A. Bassiouni, Amira M. Badr, Rehab A. Ali. Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors. Biochemical Pharmacology 2019; 164: 252 doi: 10.1016/j.bcp.2019.04.018
|
| 39 |
Gabriel Perri Esteves, Camila Sanches Manca, Hellen Paraguassú Veida-Silva, Paula Payão Ovidio, Héric Holland, Flávia Sayuri Matsuo, Mariana Kiomy Osako, Alceu Afonso Jordao. A fish oil-rich diet leads to lower adiposity and serum triglycerides but increases liver lipid peroxidation in fructose-fed rats. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00045-9
|
| 40 |
Chengyuan Liang, Juan Li, Bin Tian, Lei Tian, Yuzhi Liu, Jingyi Li, Liang Xin, Jun Wang, Chao Fu, Zhenfeng Shi, Juan Xia, Yiting Liang, Kun Wang. Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. Biomedicine & Pharmacotherapy 2021; 144: 112298 doi: 10.1016/j.biopha.2021.112298
|
| 41 |
Doaa Abdelmoneim, Mohamed El‐Adl, Gehad El‐Sayed, El Said El‐Sherbini. Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats. Fundamental & Clinical Pharmacology 2021; 35(2): 379 doi: 10.1111/fcp.12597
|
| 42 |
Kasimu G. Ibrahim, Eliton Chivandi, Pilani Nkomozepi, Mashudu G. Matumba, Emmanuel Mukwevho, Kennedy H. Erlwanger. The long‐term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high‐fructose‐fed adolescent rats. Physiological Reports 2019; 7(6): e14032 doi: 10.14814/phy2.14032
|
| 43 |
Kento Ogawa, Takashi Yagi, Tingting Guo, Katsushi Takeda, Hideomi Ohguchi, Hiroyuki Koyama, Daisuke Aotani, Kenro Imaeda, Hiromi Kataoka, Tomohiro Tanaka. Pemafibrate, a selective PPARα modulator, and fenofibrate suppress microglial activation through distinct PPARα and SIRT1-dependent pathways. Biochemical and Biophysical Research Communications 2020; 524(2): 385 doi: 10.1016/j.bbrc.2020.01.118
|
| 44 |
Oluwatomilayo Patience Ojo, Paula Andrea Perez-Corredor, Johanna Andrea Gutierrez-Vargas, Oluwole Busayo Akinola, Gloria Patricia Cardona-Gómez. Lasting metabolic effect of a high-fructose diet on global cerebral ischemia. Nutritional Neuroscience 2022; 25(6): 1159 doi: 10.1080/1028415X.2020.1841482
|
| 45 |
Ghedeir M. Alshammari, Aristatile Balakrishnan, Thirunavukkarasu Chinnasamy. Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats. BioFactors 2018; 44(3): 289 doi: 10.1002/biof.1428
|
| 46 |
María Sánchez-Aguilar, Luz Ibarra-Lara, Leonardo del Valle-Mondragón, Elizabeth Soria-Castro, Juan Carlos Torres-Narváez, Elizabeth Carreón-Torres, Alicia Sánchez-Mendoza, María Esther Rubio-Ruíz, Sainan Li. Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model. PPAR Research 2020; 2020: 1 doi: 10.1155/2020/8894525
|